Hologic Stock Today

HOLX Stock  USD 79.44  0.44  0.56%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 3

 
High
 
Low
Very Low
Hologic is trading at 79.44 as of the 28th of November 2024; that is 0.56 percent increase since the beginning of the trading day. The stock's open price was 79.0. Hologic has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on August 13, 2022, Representative Susie Lee of US Congress acquired under $15k worth of Hologic's common stock.
Business Domain
Health Care Equipment & Services
IPO Date
21st of June 1990
Category
Healthcare
Classification
Health Care
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for womens health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. Hologic, Inc. The company has 232.27 M outstanding shares of which 4.85 M shares are currently shorted by private and institutional investors with about 2.81 trading days to cover. More on Hologic

Moving against Hologic Stock

  0.61LNSR LENSAR IncPairCorr
  0.57VREX Varex Imaging CorpPairCorr
  0.57CAH Cardinal HealthPairCorr
  0.44LH LaboratoryPairCorr
  0.43UNH UnitedHealth Group Fiscal Year End 10th of January 2025 PairCorr
  0.42XAIR Beyond AirPairCorr

Hologic Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Chairman, CEO and PresStephen MacMillan
Thematic Ideas
(View all Themes)
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP 500 Index, NASDAQ Composite, SRI Sustainable Growth, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal Testing
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.09050.0862
Sufficiently Up
Slightly volatile
Asset Turnover0.760.4402
Way Up
Very volatile
Gross Profit Margin0.390.5528
Way Down
Very volatile
Total Current Liabilities1.1 BB
Sufficiently Up
Slightly volatile
Non Current Liabilities TotalBB
Way Down
Slightly volatile
Total Assets9.6 B9.2 B
Sufficiently Up
Slightly volatile
Total Current AssetsB3.8 B
Sufficiently Up
Slightly volatile
Debt Levels
Hologic can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Hologic's financial leverage. It provides some insight into what part of Hologic's total assets is financed by creditors.
Liquidity
Hologic currently holds 2.53 B in liabilities with Debt to Equity (D/E) ratio of 0.57, which is about average as compared to similar companies. Hologic has a current ratio of 3.82, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Hologic's use of debt, we should always consider it together with its cash and equity.

Net Income

828.98 Million
Hologic (HOLX) is traded on NASDAQ Exchange in USA. It is located in 250 Campus Drive, Marlborough, MA, United States, 01752 and employs 6,990 people. Hologic is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 18.35 B. Hologic conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 232.27 M outstanding shares of which 4.85 M shares are currently shorted by private and institutional investors with about 2.81 trading days to cover. Hologic currently holds about 2.39 B in cash with 1.29 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.59.
Check Hologic Probability Of Bankruptcy
Ownership Allocation
The majority of Hologic outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Hologic to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Hologic. Please pay attention to any change in the institutional holdings of Hologic as this could imply that something significant has changed or is about to change at the company. On August 13, 2022, Representative Susie Lee of US Congress acquired under $15k worth of Hologic's common stock.
Check Hologic Ownership Details

Hologic Stock Institutional Holders

InstituionRecorded OnShares
Ameriprise Financial Inc2024-06-30
3.5 M
Amvescap Plc.2024-06-30
3.4 M
Renaissance Technologies Corp2024-09-30
2.8 M
Black Creek Investment Management Inc2024-09-30
2.7 M
Manufacturers Life Insurance Co2024-09-30
2.6 M
Northern Trust Corp2024-09-30
2.5 M
Dimensional Fund Advisors, Inc.2024-09-30
2.5 M
Norges Bank2024-06-30
2.4 M
Bank Of America Corp2024-06-30
2.4 M
Vanguard Group Inc2024-09-30
27 M
Blackrock Inc2024-06-30
23.1 M
View Hologic Diagnostics

Hologic Historical Income Statement

At this time, Hologic's Net Income is fairly stable compared to the past year. Research Development is likely to rise to about 286.4 M in 2024, whereas Interest Expense is likely to drop slightly above 74.8 M in 2024. View More Fundamentals

Hologic Stock Against Markets

Hologic Corporate Management

Mark IrvingVP SecretaryProfile
Paul MalenchiniChief OfficerProfile
Peter DunneSenior ResourcesProfile
Benjamin CohnPrincipal Chief Accounting OfficerProfile
Erik AndersonDivision SolutionsProfile
Kevin ThornalGroup SolutionsProfile

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.